FAM72A and hepatocellular carcinoma: Additionally, FAM72A is overexpressed in various cancers, such as glioma (including glioblastoma multiform) [11,12], lung adenocarcinoma (LUAD) [13], hepatocellular carcinoma (HCC) [14,15], breast invasive carcinoma (BRCA) [16], and uterine corpus endometrial carcinoma (UCEC) [17], and is associated with poor prognosis, serving as a prognostic biomarker for multiple cancers.